Status:

TERMINATED

Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy

Lead Sponsor:

Regional Hospital Holstebro

Conditions:

Kidney Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this project is to investigate if hydroxyethyl starch (HES) is potential nephrotoxic and examine the effects on the circulation and kidneys during administration of HES during surgery.

Detailed Description

Hydroxyethyl starch (HES) is widely used in hospitals to maintain circulation in critically ill patients. In recent years studies have raised suspicion that HES is nephrotoxic. So far acute kidney inj...

Eligibility Criteria

Inclusion

  • Age \> 18 years
  • Males and females
  • Indication for laparoscopic nephrectomy

Exclusion

  • Blood donation within the last month
  • Lack of wish to participate
  • eGFR\< 15ml/min
  • Pregnancy or breast feeding

Key Trial Info

Start Date :

December 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2014

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT01486550

Start Date

December 1 2011

End Date

September 1 2014

Last Update

October 9 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medicinck forskningsafsnit, Regionshospitalet Holstebro

Holstebro, Denmark, 7500